Macrogenics (MGNX) Inventory (2021 - 2026)

Macrogenics (MGNX) has reported Inventory for 6 consecutive years, with $9.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory rose 1.06% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (up 1.06% YoY), while the FY2025 annual figure was $7.9 million, changed N/A from the prior year.
• Inventory grew to $9.5 million in Q1 2026 per MGNX's latest filing, from $7.9 million in the prior quarter.
• Across five years, Inventory topped out at $9.5 million in Q1 2026 and bottomed at $1.1 million in Q3 2023.
• Historically, Inventory has averaged $4.1 million across 5 years, with a median of $2.2 million in 2022.
• Annual changes were most pronounced in 2022 — Inventory sank 72.71% — and 2025, when it surged 734.08%.
• Macrogenics' Inventory stood at $1.5 million in 2022, then retreated by 15.85% to $1.2 million in 2023, then jumped by 165.68% to $3.2 million in 2024, then jumped by 143.83% to $7.9 million in 2025, then climbed by 20.1% to $9.5 million in 2026.
• Business Quant data shows MGNX's Inventory at $9.5 million in Q1 2026, $7.9 million in Q4 2025, and $8.8 million in Q3 2025.